Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To determine whether targeting lower arterial oxygen saturations from the day of birth alters the early (first 3 months) postnatal development of the control of ventilation and the hypercapnic and hyperoxic responses in very preterm infants.
To measure the effects of baseline oxygenation in extremely low birth weight preterm infants on:
i) The early (first 5 breaths) and late or steady state (3-5 minutes) ventilatory response to CO2 ii) The immediate (< 1 minute) ventilatory response to hyperoxia iii) The PCO2 apneic threshold iv) The breathing pattern during quiet and REM sleep v) The morphology of periodic breathing cycles vi) The incidence and morphology of sighs
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| High | Active Comparator | Arterial oxygen saturations in the range of 91-95% |
|
| Low | Experimental | Arterial oxygen saturations in the range of 85-89% |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Oxygen saturation range | Other | Maintain functional oxygen saturation range between 91 and 95% |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Effects of targeting lower arterial oxygen saturations on the development of control of breathing in very preterm infants | 3 months |
| Measure | Description | Time Frame |
|---|---|---|
| To measure the effects of baseline oxygenation in extremely low birth weight preterm infants on the ventilatory response to CO2 and O2, the PCO2 apneic threshold, and the baseline breathing pattern | 3 months |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Ruben E Alvaro, MD | University of Manitoba | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| St. Boniface General Hospital | Winnipeg | Manitoba | R2H 2A6 | Canada | ||
| Health Science Centre |
Not provided
Not provided
Not provided
Not provided
Not provided
| Oxygen saturation range |
| Other |
Maintain functional arterial oxygen saturations in the range of 85- 89% |
|
| Winnipeg |
| Manitoba |
| R3E 0L8 |
| Canada |